Manulife (Manufacturers Life Insurance)’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.14M Buy
10,021
+252
+3% +$28.6K ﹤0.01% 1762
2025
Q1
$1.03M Buy
9,769
+396
+4% +$41.6K ﹤0.01% 1801
2024
Q4
$1M Buy
9,373
+779
+9% +$83.5K ﹤0.01% 1904
2024
Q3
$860K Sell
8,594
-167
-2% -$16.7K ﹤0.01% 1998
2024
Q2
$738K Buy
8,761
+407
+5% +$34.3K ﹤0.01% 2017
2024
Q1
$611K Buy
8,354
+90
+1% +$6.58K ﹤0.01% 2117
2023
Q4
$590K Sell
8,264
-278
-3% -$19.9K ﹤0.01% 2104
2023
Q3
$512K Buy
8,542
+1,759
+26% +$105K ﹤0.01% 2126
2023
Q2
$489K Buy
6,783
+614
+10% +$44.3K ﹤0.01% 2047
2023
Q1
$454K Buy
6,169
+31
+0.5% +$2.28K ﹤0.01% 2068
2022
Q4
$410K Sell
6,138
-3,536
-37% -$236K ﹤0.01% 2114
2022
Q3
$520K Sell
9,674
-152
-2% -$8.17K ﹤0.01% 1957
2022
Q2
$547K Sell
9,826
-201
-2% -$11.2K ﹤0.01% 1994
2022
Q1
$704K Sell
10,027
-2,242
-18% -$157K ﹤0.01% 1965
2021
Q4
$1.18K Sell
12,269
-401
-3% -$39 ﹤0.01% 1732
2021
Q3
$1.1M Sell
12,670
-29,676
-70% -$2.58M ﹤0.01% 1780
2021
Q2
$3.47M Sell
42,346
-89
-0.2% -$7.29K ﹤0.01% 1420
2021
Q1
$4.04M Sell
42,435
-208,128
-83% -$19.8M ﹤0.01% 1346
2020
Q4
$15.5M Buy
250,563
+41,115
+20% +$2.55M 0.01% 698
2020
Q3
$12.5M Buy
209,448
+9,935
+5% +$591K 0.01% 708
2020
Q2
$14.1M Sell
199,513
-8,074
-4% -$569K 0.01% 647
2020
Q1
$9.42M Sell
207,587
-411,702
-66% -$18.7M 0.01% 742
2019
Q4
$40.3M Sell
619,289
-428
-0.1% -$27.8K 0.04% 367
2019
Q3
$38.3M Sell
619,717
-117,172
-16% -$7.23M 0.04% 384
2019
Q2
$52.5M Sell
736,889
-156,803
-18% -$11.2M 0.06% 292
2019
Q1
$70.1M Buy
893,692
+244,697
+38% +$19.2M 0.08% 242
2018
Q4
$54.9M Buy
648,995
+103,233
+19% +$8.74M 0.07% 271
2018
Q3
$93.5M Sell
545,762
-3,056
-0.6% -$523K 0.1% 205
2018
Q2
$70.9M Buy
548,818
+524,526
+2,159% +$67.8M 0.08% 255
2018
Q1
$2.5M Sell
24,292
-696
-3% -$71.7K ﹤0.01% 1423
2017
Q4
$2.13M Buy
24,988
+255
+1% +$21.8K ﹤0.01% 1461
2017
Q3
$2.1M Sell
24,733
-322
-1% -$27.3K ﹤0.01% 1414
2017
Q2
$1.9M Buy
25,055
+1,436
+6% +$109K ﹤0.01% 1475
2017
Q1
$1.56M Buy
23,619
+2,830
+14% +$187K ﹤0.01% 1524
2016
Q4
$1.32M Buy
20,789
+57
+0.3% +$3.61K ﹤0.01% 1545
2016
Q3
$1.32M Buy
20,732
+138
+0.7% +$8.79K ﹤0.01% 1512
2016
Q2
$1.53M Buy
20,594
+1,889
+10% +$141K ﹤0.01% 1424
2016
Q1
$1.23M Buy
18,705
+344
+2% +$22.5K ﹤0.01% 1528
2015
Q4
$1.24K Buy
18,361
+175
+1% +$12 ﹤0.01% 1522
2015
Q3
$972 Buy
18,186
+497
+3% +$27 ﹤0.01% 1615
2015
Q2
$1.11K Sell
17,689
-3,233
-15% -$203 ﹤0.01% 1629
2015
Q1
$1.01K Buy
20,922
+170
+0.8% +$8 ﹤0.01% 1680
2014
Q4
$688 Sell
20,752
-889
-4% -$29 ﹤0.01% 1806
2014
Q3
$634 Sell
21,641
-75,576
-78% -$2.21K ﹤0.01% 1840
2014
Q2
$3.78M Buy
97,217
+75,488
+347% +$2.93M 0.01% 1136
2014
Q1
$911 Sell
21,729
-136
-0.6% -$6 ﹤0.01% 1686
2013
Q4
$717 Sell
21,865
-152
-0.7% -$5 ﹤0.01% 1819
2013
Q3
$594 Sell
22,017
-215
-1% -$6 ﹤0.01% 1885
2013
Q2
$519K Buy
+22,232
New +$519K ﹤0.01% 1868